https://scholars.lib.ntu.edu.tw/handle/123456789/496057
標題: | Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes | 作者: | CHIN-HSIAO TSENG | 公開日期: | 2018 | 出版社: | Elsevier Masson SAS | 卷: | 44 | 期: | 1 | 起(迄)頁: | 77-79 | 來源出版物: | Diabetes and Metabolism | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023754057&doi=10.1016%2fj.diabet.2017.05.011&partnerID=40&md5=482b0a1902d67a4d5fa1d0aa675ea6de https://scholars.lib.ntu.edu.tw/handle/123456789/496057 |
ISSN: | 1262-3636 | DOI: | 10.1016/j.diabet.2017.05.011 | SDG/關鍵字: | pioglitazone; 2,4 thiazolidinedione derivative; antidiabetic agent; pioglitazone; age; cancer incidence; cancer patient; cancer risk; chronic obstructive lung disease; diabetic patient; disease duration; drug exposure; hazard ratio; human; ICD-9; Letter; lung cancer; major clinical study; non insulin dependent diabetes mellitus; priority journal; propensity score; sex; Taiwanese; tobacco dependence; case control study; complication; lung tumor; non insulin dependent diabetes mellitus; Taiwan; Case-Control Studies; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lung Neoplasms; Taiwan; Thiazolidinediones |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。